FDA Inspection 1148358 — Paradox Inc

Paradox Inc — FEI 1927976

The FDA completed an inspection of Paradox Inc on August 4, 2021 in Saint Joseph, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 4, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Saint Joseph, MO (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
126321 CFR 211.68(b)Computer control of master formula records
189021 CFR 211.165(e)Test methods
202721 CFR 211.192Investigations of discrepancies, failures